Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
Dan Cai,
Si Shi,
Shan Jiang,
Lei Si,
Jing Wu () and
Yawen Jiang
Additional contact information
Dan Cai: Sun Yat-Sen University
Si Shi: Sun Yat-Sen University
Shan Jiang: University of British Columbia
Lei Si: UNSW Sydney
Jing Wu: Tianjin University
The European Journal of Health Economics, 2022, vol. 23, issue 4, No 4, 607-615
Abstract:
Abstract Cost-effective threshold (CET) is essential for health technology assessment and decision-making based on health economic evaluations. Recently, it has been argued that the commonly used once and three times of gross domestic product (GDP) per capita CETs of a quality-adjusted life year (QALY) are not necessarily empirically supported in all countries. Therefore, we aimed to estimate the CET of a QALY as times of GDP per capita in China, of which the reimbursement coverage decisions are increasingly engaging economic evaluations. Estimates on the value of statistical life (VSL) in China were identified from several studies in the literature and converted to times of GDP per capita, the weighted average of which was used for subsequent calculation. By pooling data on population mortality, health utility, and age distribution, we estimated the value of a statistical QALY (VSQ) from VSL using an established mathematical process, which represented the theoretical upper bound of CET. The corresponding point estimate and theoretical lower bound were obtained using their numerical relationships with the upper bound. Scenarios analyses were also conducted. The estimated CET, its upper bound, and its lower bound were 1.45, 2.90, and 1.16 times of GDP per capita in China, respectively. In different scenarios, the estimated CET varied but was greater than once GDP per capita in most cases. As such, the CET of a QALY in China is close to 1.5 times of GDP per capita, which should be benchmarked for future ICER-based coverage decisions.
Keywords: Willingness-to-pay; QALY; Threshold; China; I18 (search for similar items in EconPapers)
JEL-codes: I18 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
http://link.springer.com/10.1007/s10198-021-01384-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:23:y:2022:i:4:d:10.1007_s10198-021-01384-z
Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2
DOI: 10.1007/s10198-021-01384-z
Access Statistics for this article
The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg
More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().